Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −6 vs. Q2 2021
- Shares held
- 16.1M
- −563.6K (−3.4%) vs. Q2 2021
- Total value
- $26.0M
- −$7.14M (−21.5%) vs. Q2 2021
- New holders
- 8
- 12 more added
- Sold out
- 14
- 12 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,047,038 | $4.97M | 0.00% | −8,479−0.3% | Reduced |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $3.41M | 0.05% | 00.0% | Unchanged |
| American Financial Group Inc | 1,480,000 | $2.41M | 0.64% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,259,840 | $2.05M | 1.19% | −627,699−33.3% | Reduced |
| Nantahala Capital Management, LLC | 1,209,338 | $1.97M | 0.12% | −1,056,949−46.6% | Reduced |
| Altshuler Shaham Ltd | 1,157,540 | $1.90M | 0.01% | 00.0% | Unchanged |
| Altium Capital Management LP | 1,118,000 | $1.82M | 0.49% | +447,882+66.8% | Added |
| Geode Capital Management, LLC | 772,836 | $1.26M | 0.00% | +245,529+46.6% | Added |
| Two Sigma Advisers, LP | 705,300 | $1.15M | 0.00% | +480,800+214.2% | Added |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $954.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 490,871 | $800.0K | 0.00% | +300,153+157.4% | Added |
| Two Sigma Investments, LP | 314,874 | $513.0K | 0.00% | +208,374+195.7% | Added |
| Vanguard Capital Wealth Advisors | 437,900 | $457.0K | 0.35% | +312,900+250.3% | Added |
| Millennium Management LLC | 274,297 | $447.0K | 0.00% | −119,406−30.3% | Reduced |
| State Street Corp | 194,403 | $317.0K | 0.00% | +5,200+2.7% | Added |
| Northern Trust Corp | 124,369 | $202.0K | 0.00% | −12,503−9.1% | Reduced |
| Simplex Trading, LLC | 95,702 | $191.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 104,288 | $170.0K | 0.00% | +2,628+2.6% | Added |
| Natixis | 103,900 | $170.0K | 0.00% | +103,900 | New |
| Bridgeway Capital Management, LLC | 91,400 | $149.0K | 0.00% | −57,600−38.7% | Reduced |
| Bank of New York Mellon Corp | 76,122 | $124.0K | 0.00% | +64,183+537.6% | Added |
| D. E. Shaw & Co., Inc. | 63,698 | $104.0K | 0.00% | +63,698 | New |
| Susquehanna International Group, LLP | 45,044 | $73.0K | 0.00% | +14,282+46.4% | Added |
| Occudo Quantitative Strategies LP | 41,642 | $68.0K | 0.01% | −605−1.4% | Reduced |
| Private Advisor Group, LLC | 32,510 | $52.0K | 0.00% | +32,510 | New |
| Goldman Sachs Group Inc | 27,588 | $45.0K | 0.00% | +27,588 | New |
| Meeder Asset Management Inc | 25,778 | $41.0K | 0.00% | +5,321+26.0% | Added |
| Price T Rowe Associates Inc | 22,700 | $37.0K | 0.00% | +22,700 | New |
| Wells Fargo & Company | 21,370 | $36.0K | 0.00% | −85−0.4% | Reduced |
| ExodusPoint Capital Management, LP | 19,720 | $32.0K | 0.00% | +19,720 | New |
| Mesirow Financial Investment Management, Inc. | 18,894 | $31.0K | 0.09% | 00.0% | Unchanged |
| Sawtooth Solutions, LLC | 16,201 | $26.0K | 0.00% | +16,201 | New |
| Advisor Group Holdings, Inc. | 12,359 | $20.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 11,120 | $18.0K | 0.00% | −1,239−10.0% | Reduced |
| Bank of America Corp | 6,077 | $9.00K | 0.00% | +5,141+549.3% | Added |
| Barclays PLC | 3,678 | $6.00K | 0.00% | −2,775−43.0% | Reduced |
| BNP Paribas Arbitrage, SA | 722 | $1.18K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 793 | $1.00K | 0.00% | −19,368−96.1% | Reduced |
| FMR LLC | 338 | $1.00K | 0.00% | +338 | New |
| Brewin Dolphin Ltd | 15 | $24 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 41 | $0 | 0.00% | −1,272−96.9% | Reduced |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −367,062−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −163,900−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −121,900−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −83,344−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −74,056−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −68,000−100.0% | Sold out |
| Gratia Capital, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −46,884−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −14,435−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −12,034−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11,635−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,612−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,587−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −228−100.0% | Sold out |